approval
saveAMJEVITA (ADALIMUMAB-ATTO) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalOct 16, 2025 · 351d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalSep 17, 2025 · 380d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalMay 20, 2025 · 500d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 7, 2025 · 543d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAug 20, 2024 · 773d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalJul 12, 2023 · 1178d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 6, 2023 · 1275d ago
- approvalAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalMar 22, 2023 · 1290d ago
same company · ±60 days · 4
🐶 often sniffed alongside
top 8- tagApproval214 co-mentions · 94 sources
- drugHUMIRA188 co-mentions · 94 sources
- drugadalimumab168 co-mentions · 94 sources
- drugYUSIMRY81 co-mentions · 81 sources
- drugABRILADA81 co-mentions · 81 sources
- company$ABBVAbbVie Inc.61 co-mentions · 61 sources
- company$AMGNAMGEN INC26 co-mentions · 13 sources
- drugCYLTEZO24 co-mentions · 12 sources
comments(0)
5-min edit window · permanent after that